FTH Faeth Therapeutics, Inc.

NASDAQ
$34.50

Faeth Therapeutics, Inc. (FTH) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 0 buyers in the last 30 days 2 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
2
23 transactions
Insiders selling
0
0 transactions
Purchases
$1.2M
49,494 shares
Sales
$0
0 shares
Net activity
$1.2M
purchases less sales

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: July 1, 2026 , by STEPHENSON BRIAN C .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
STEPHENSON BRIAN C 2 fills Chief Financial Officer Buy 5,000 $23.50 $117.5K 46,688
STEPHENSON BRIAN C 3 fills Chief Financial Officer Buy 7,803 $24.25 $189.2K 41,688
STEPHENSON BRIAN C Chief Financial Officer Buy 831 $23.34 $19.4K 33,885
STEPHENSON BRIAN C 4 fills Chief Financial Officer Buy 6,250 $24.95 $155.9K 33,054
STEPHENSON BRIAN C 4 fills Chief Financial Officer Buy 9,391 $26.13 $245.4K 26,804
STEPHENSON BRIAN C 3 fills Chief Financial Officer Buy 9,230 $24.36 $224.8K 17,413
STEPHENSON BRIAN C 5 fills Chief Financial Officer Buy 8,183 $22.13 $181.1K 8,183
Parikh Anand Kiran President and CEO Buy 2,806 $19.76 $55.4K 764,234

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.